Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune-mediated demyelination

H P Hartung1

  • 1Clinical Research Group for Multiple Sclerosis, Julius-Maximilians-Universität Würzburg, Germany.

Annals of Neurology
|June 1, 1993
PubMed
Summary
This summary is machine-generated.

Tumor necrosis factor-alpha (TNF-alpha) and intercellular adhesion molecule-1 (ICAM-1) play roles in Guillain-Barré syndrome (GBS) and multiple sclerosis (MS). These molecules may be targets for treating these inflammatory demyelinating diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction to: The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Journal of neurology·2022
Same author

The current standing of autologous haematopoietic stem cell transplantation for the treatment of multiple sclerosis.

Journal of neurology·2022
Same author

Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis.

Journal of neurology·2020
Same author

[Multiple sclerosis and hepatitis B vaccination : What does the verdict of the European Court of Justice on liability after vaccination mean?]

Der Nervenarzt·2018
Same author

ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

European journal of neurology·2018
Same author

Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.

Journal of neurology·2016

Area of Science:

  • Neuroimmunology
  • Molecular Medicine

Background:

  • Guillain-Barré syndrome (GBS) and multiple sclerosis (MS) are immune-mediated demyelinating diseases.
  • Aberrant immune responses to myelin antigens are implicated in the pathogenesis of GBS and MS.

Discussion:

  • Elevated tumor necrosis factor-alpha (TNF-alpha) levels are found in GBS patients, suggesting its role in inflammatory demyelination.
  • Intercellular adhesion molecule-1 (ICAM-1) is elevated in active MS, potentially facilitating T lymphocyte migration to the brain.
  • Both TNF-alpha and ICAM-1 contribute to the inflammatory processes in GBS and MS.

Key Insights:

  • TNF-alpha contributes to GBS pathogenesis through various mechanisms including endothelial damage and direct myelin injury.
  • ICAM-1 is crucial for autoreactive T lymphocyte trafficking in multiple sclerosis.

Related Experiment Videos

  • Elevated TNF-alpha and ICAM-1 levels in GBS and MS patients indicate their involvement in disease activity.

    • Outlook:

    • Further investigation is needed to determine if ICAM-1 can serve as a biomarker for acute inflammatory events in MS relapses.
    • Targeting TNF-alpha and ICAM-1 offers potential for antigen-nonspecific therapeutic strategies in GBS and MS.
    • Understanding the roles of TNF-alpha and ICAM-1 can lead to novel treatments for inflammatory demyelinating diseases.